The debate highlighted that SCFAs have limited blood-brain barrier penetrance, but specific CNS concentration thresholds for therapeutic efficacy remain unknown. This dosing gap is critical for developing viable gut-brain axis interventions. Source: Debate session sess_gut-brain-ad (Analysis: gut-brain-ad)
Landscape Summary: What are the minimum therapeutic SCFA concentrations needed in brain tissue to achieve microglial reprogramming? is a 0.82 priority gap in neuropharmacology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the minimum therapeutic SCFA concentrations needed in brain tissue to achieve microglial reprogramming? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: